Showing results (111-120 of 299) with videos related to

Sort By:
Pageof 30
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expressionElizabeth Mayne, Nicholas T Funderburg, Scott F Sieg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.
Cell Reports|March 1, 2016
IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life CycleMayte Coiras, Mercedes Bermejo, Benjamin Descours, et al.
Iscience|March 4, 2022
Immunomodulatory potential of <i>in vivo</i> natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaquesNell G Bond, Marissa D Fahlberg, Shan Yu, et al.
AIDS (London, England)|May 11, 2002
HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigensHernan Valdez, Nicole L Carlson, Anthony B Post, et al.
Pediatric Research|January 20, 2012
Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurityMaricruz Crespo, Denise G Martinez, Adam Cerissi, et al.
The Journal of Infectious Diseases|January 9, 2018
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral TherapyKonstantia Angelidou, Peter W Hunt, Alan L Landay, et al.
The Journal of Infectious Diseases|November 19, 2003
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimenAlan L Landay, John Spritzler, Harold Kessler, et al.
Clinical Immunology (Orlando, Fla.)|September 23, 2003
CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitroJanelle R Salkowitz, Shannon E Bruse, Howard Meyerson, et al.
Clinical and Vaccine Immunology : CVI|July 16, 2010
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181Bernard J C Macatangay, Lu Zheng, Charles R Rinaldo, et al.
Pageof 30